Structure-activity relationships of 2,3-benzodiazepine compounds with glutamate antagonistic action

This publication has 10 references indexed in Scilit:

• Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat.
  Stroke, 1992
• The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat
  Brain Research, 1992
• Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus
  Neuroscience Letters, 1991
• The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy
  European Journal of Pharmacology, 1991
• The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice
  Epilepsy Research, 1991
• GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones
  Neuroscience Letters, 1991
• Excitatory amino acid neurotoxicity and neurodegenerative disease
  Trends in Pharmacological Sciences, 1990
• Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466
  European Journal of Pharmacology, 1989
• Effects of new non‐N‐methyl‐D‐aspartate antagonists on synaptic transmission in the in vitro rat hippocampus.
  The Journal of Physiology, 1989
• Blockade of excitatory synaptic transmission by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) in the hippocampus in vitro
  Neuroscience Letters, 1988